Home » Topics » BioWorld Science

BioWorld Science
RSS

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Genes associated with latent CMV infection discovered

Oct. 11, 1996

Azole antifungals reported by Takeda

Oct. 11, 1996

Xoma poised to enter pivotal trials with Neuprex

Oct. 11, 1996

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

Daiichi discloses quinolone antibacterial agents

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...